Varman T. Samuel MD, PhD
Associate Professor of Medicine, Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut; Section Chief, Endocrinology, VA Connecticut Healthcare SystemDr. Varman T. Samuel is an adult endocrinologist with a particular interest in the exploring the mechanisms by which the development of nonalcoholic fatty liver disease impacts hepatic insulin action and hepatic carbohydrate metabolism. His research interests include the role of the sn 1,2-diacyglycerol-PKCε pathway for insulin resistance, the role of pyruvate carboxylase in regulating hepatic gluconeogenesis, the impact of dietary fructose on the development of insulin resistance and recently, the intersection between alcoholic- and non-alcoholic fatty liver disease. He is currently an Associate Professor of Medicine at Yale University School of Medicine and chief of Endocrinology for VA Connecticut Healthcare System.
Disclosures
Dr. Samuel has no relevant disclosures.Recent Contributions to PracticeUpdate:
- Racial and Ethnic Disparities in Early Glycemic Control Trends Among Veterans With Newly Diagnosed Type 2 Diabetes
- Role of Adipose Tissue Insulin Resistance in Predicting the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD
- Impact of NAFLD and the Transition to Metabolically Unhealthy Obesity on CVD Risk